Sept. 28: C/T Seminar Series Features David Watkins, Ph.D.
Please join us as David Watkins, Ph.D., Vice Chair of Research in the Department of Pathology, presents, “Antibody Responses Against Zika: Implications for Diagnostics and Prevention,” on Wednesday, September 28 from 4 to 5 p.m., at the Mailman Center for Child Development, room 3023. Click here to reserve your spot.
Dr. Watkins will discuss the immune response to Zika virus during the acute and chronic phase. His team has isolated more than 100 monoclonal antibodies from infected patients. He will describe how these antibodies bind to and neutralize Zika and the closely related flavivirus, Dengue, and the implications for Zika diagnostics, prevention and treatment.
Dr. Watkins is an accomplished investigator studying the mechanisms of viral evasion from the immune system, joined the Miller School faculty in 2012 as professor and Vice Chair of Research in the Department of Pathology. Watkins and his lab are focused on the development of vaccines for viruses that affect millions of people worldwide, particularly HIV and dengue fever and most recently Zika. He is using human monoclonal antibodies in prevention and therapy strategies against Dengue and Zika. Additionally, he and his research team investigate novel ways to make an effective vaccine against HIV using the yellow fever vaccine. In May 2016, Dr. Watkins and his collaborators received a large grant from the Bill & Melinda Gates Foundation to study the impact of the Zika virus in laboratory animals.